110 related articles for article (PubMed ID: 1930176)
1. Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine HCl, a potent ligand for intracellular histamine receptors.
Brandes LJ; Beecroft WA; Hogg GR
Biochem Biophys Res Commun; 1991 Sep; 179(3):1297-304. PubMed ID: 1930176
[TBL] [Abstract][Full Text] [Related]
2. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
Brandes LJ; LaBella FS; Warrington RC
J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
[TBL] [Abstract][Full Text] [Related]
3. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver.
Brandes LJ; Davie JR; Paraskevas F; Sukhu B; Bogdanovic RP; LaBella FS
Agents Actions Suppl; 1991; 33():325-42. PubMed ID: 2053513
[TBL] [Abstract][Full Text] [Related]
4. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
Brandes LJ; Hogg GR
J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.
Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS
Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253
[TBL] [Abstract][Full Text] [Related]
6. A novel non-H1, non-H2 histamine antagonist protects against cysteamine-induced duodenal ulcers in rats.
Glavin GB; Brandes LJ
Pharmacology; 1988; 37(5):277-80. PubMed ID: 3237758
[TBL] [Abstract][Full Text] [Related]
7. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the gastroprotective effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine hydrochloride, a non-H1/non-H2 histamine antagonist.
Glavin GB; Gerrard JM
Digestion; 1990; 47(3):143-8. PubMed ID: 2083800
[TBL] [Abstract][Full Text] [Related]
9. Histamine and calcium are independently regulated intracellular mediators of lymphocyte mitogenesis.
Brandes LJ; LaBella FS
Biochem Biophys Res Commun; 1992 Jan; 182(2):786-93. PubMed ID: 1310395
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding site.
Brandes LJ; Bogdanovic RP; Cawker MD; Bose R
Cancer Chemother Pharmacol; 1986; 18(1):21-3. PubMed ID: 3757154
[TBL] [Abstract][Full Text] [Related]
11. A role for intracellular histamine in ultrastructural changes induced in platelets by phorbol esters.
McNicol A; Saxena SP; Brandes LJ; Gerrard JM
Arteriosclerosis; 1989; 9(5):684-9. PubMed ID: 2783081
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
Brandes LJ; Arron RJ; Bogdanovic RP; Tong J; Zaborniak CL; Hogg GR; Warrington RC; Fang W; LaBella FS
Cancer Res; 1992 Jul; 52(13):3796-800. PubMed ID: 1617649
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
Kudoh K; Kikuchi Y; Hiramatsu H; Hirata J; Yamamoto K; Kita T; Nagata I
Eur J Cancer; 1997 Jan; 33(1):122-8. PubMed ID: 9071911
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a dual role of endogenous histamine in angiogenesis.
Norrby K
Int J Exp Pathol; 1995 Apr; 76(2):87-92. PubMed ID: 7540412
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the antiestrogen binding site is a histamine or histamine-like receptor.
Brandes LJ; Macdonald LM; Bogdanovic RP
Biochem Biophys Res Commun; 1985 Jan; 126(2):905-10. PubMed ID: 2858205
[TBL] [Abstract][Full Text] [Related]
16. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Brandes LJ; Queen GM; LaBella FS
Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
[TBL] [Abstract][Full Text] [Related]
17. Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood-brain barrier permeability in the rat.
Deli MA; Németh L; Falus A; Abrahám CS
Eur J Pharmacol; 2000 Jan; 387(1):63-72. PubMed ID: 10633162
[TBL] [Abstract][Full Text] [Related]
18. Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents.
Brandes LJ; Simons KJ; Bracken SP; Warrington RC
J Clin Oncol; 1994 Jun; 12(6):1281-90. PubMed ID: 8201390
[TBL] [Abstract][Full Text] [Related]
19. New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
Brandes LJ; Bogdanovic RP
Biochem Biophys Res Commun; 1986 Jan; 134(2):601-8. PubMed ID: 3947341
[TBL] [Abstract][Full Text] [Related]
20. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.
Hiramatsu H; Kikuchi Y; Kudoh K; Kita T; Tode T; Nagata I
Jpn J Cancer Res; 1997 Oct; 88(10):1003-8. PubMed ID: 9414663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
